149 related articles for article (PubMed ID: 8698067)
1. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.
Würker M; Herholz K; Voges J; Pietrzyk U; Treuer H; Bauer B; Sturm V; Heiss WD
Eur J Nucl Med; 1996 May; 23(5):583-6. PubMed ID: 8698067
[TBL] [Abstract][Full Text] [Related]
2. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
4. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Vlassenko AG; Thiessen B; Beattie BJ; Malkin MG; Blasberg RG
J Neurooncol; 2000; 46(3):249-59. PubMed ID: 10902856
[TBL] [Abstract][Full Text] [Related]
6. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
8. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
12. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
[TBL] [Abstract][Full Text] [Related]
15. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
17. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.
Derlon JM; Chapon F; Noël MH; Khouri S; Benali K; Petit-Taboué MC; Houtteville JP; Chajari MH; Bouvard G
Eur J Nucl Med; 2000 Jul; 27(7):778-87. PubMed ID: 10952489
[TBL] [Abstract][Full Text] [Related]
19. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Ogawa T; Inugami A; Hatazawa J; Kanno I; Murakami M; Yasui N; Mineura K; Uemura K
AJNR Am J Neuroradiol; 1996 Feb; 17(2):345-53. PubMed ID: 8938309
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
